# AMD 3100 (Mozobil Plerixafor) to Mobilize Stem Cells for Donation

> **NCT00075335** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AMD3100 (Mozobil plerixafor)

## Key facts

- **NCT ID:** NCT00075335
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2018-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00075335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00075335, "AMD 3100 (Mozobil Plerixafor) to Mobilize Stem Cells for Donation". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00075335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*